Register for OBR daily


IMS_White_300x250

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

TGTX $11.45 1.4600 +14.61%
CTIC $2.82 0.3050 +12.15%
IMUC $0.97 0.0826 +9.28%
HALO $9.70 0.6600 +7.30%
VSTM $9.51 0.5960 +6.69%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

ONCY $0.76 -0.5089 -40.07%
ADXS $3.30 -0.2299 -6.51%
ARGS $8.35 -0.5100 -5.76%
GTXI $0.75 -0.0431 -5.45%
OHRP $7.97 -0.3100 -3.74%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | Next > | Last >>

NIH Issues Finalized Policy on Genomic Data Sharing

(NIH News) Aug 27, 2014 - The National Institutes of Health has issued a final NIH Genomic Data Sharing (GDS) policy to promote data sharing as a way to speed the translation of data into knowledge, products and procedures that improve health while protecting the privacy of research participants.
read press release 



IBM’s Watson Goes From Jeopardy Player to Scientist Used by J&J

(Bloomberg) Aug 28, 2014 - International Business Machines Corp. wants you to know that its Watson technology can do more than win “Jeopardy!”-- it can now help accelerate scientific research and discoveries.
read article 



FDA Says Johnson & Johnson Recalls Some Jaw Implants

(Reuters) Aug 28, 2014 - Johnson & Johnson is recalling some lots of its implant used to correct defects of the jaw following more than a dozen cases of injury.
read article 



Amgen Submits U.S. Application to Sell Cholesterol-Fighting Drug

(Reuters) Aug 28, 2014 - Amgen Inc said it submitted an application to the U.S. Food and Drug Administration to market its cholesterol-lowering drug, evolocumab.
read article 



Officials Announce Ebola Vaccine Trial Launch

(USA Today) Aug 28, 2014 - The USA plans to begin testing an experimental Ebola vaccine next month, but even in the best case, it won't become available until next year.
read article 



CBO Projects Lower Medicare and Medicaid Costs

(Kaiser Health News/Capsules blog) Aug 27, 2014 - Reduced costs for medical services and labor have trimmed the 10-year projected cost of Medicare and Medicaid by $89 billion, the Congressional Budget Office said Wednesday.
read article 



AACR to Co-host 2014 Turning the Tide Against Cancer National Conference

(AACR) Aug 26, 2014 - The American Association for Cancer Research (AACR), the Personalized Medicine Coalition, and Feinstein Kean Healthcare are convening the second national conference on Turning the Tide Against Cancer Through Sustained Medical Innovation which will be held 8:30 a.m. to 4 p.m., Oct. 9, at the Knight Conference Center at the Newseum in Washington, D.C.
read press release 



Houston’s Bellicum Nets $55M to Boost Trials For Cancer Treatment

(Xconomy Texas) Aug 27, 2014 - Houston biotech firm Bellicum Pharmaceuticals announced Wednesday it has raised $55 million in a Series C financing.
read article 



The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine

(LLS) Aug 28, 2014 - The Leukemia & Lymphoma Society (LLS) and OncoPep have entered a partnership to advance an experimental cancer vaccine to treat patients with smoldering multiple myeloma (SMM), an asymptomatic stage of myeloma.
read press release 



ERYTECH Announces Second Positive DSMB Review of Its Phase IIb Study in Acute Myeloid Leukemia

(Yahoo! Finance) Aug 27, 2014 - ERYTECH Pharma announces that an independent Data and Safety Monitoring Board (DSMB) completed its second safety assessment of the company’s Phase IIb study in Acute Myeloid Leukemia (AML) and unanimously recommended continuation of the trial without modification.
read article 



Pilot Program Aims to Improve Colorectal Cancer Screening Rates, Access to Specialty Care in Community Health Centers

(ACS) Aug 27, 2014 - Three locations will each receive $100,000 in funding to launch pilot programs to improve colorectal cancer screening rates and follow-up care for patients served by community health centers.
read press release 



New Tool Clarifies Drug Reimbursement For Cancer Patients

(Medscape Medical News) Aug 27, 2014 - A new tool that evaluates insurance coverage for specific cancer therapies might be useful for oncologists and their patients weighing different treatment options.
read article (free registration required) 



Rinse Eases Symptoms of Oral Mucositis in Cancer Patients

(Medscape Medical News) Aug 27, 2014 - A rinse for oral mucositis has been shown to offer significantly better symptom improvement than placebo in a randomized controlled trial.
read article (free subscription required) 



Risk of Diabetes Up in Hodgkin’s Lymphoma Survivors

(Doctors Lounge/HealthDay News) Aug 27, 2014 - Para-aortic radiation correlates with increased diabetes mellitus risk for Hodgkin's lymphoma survivors, according to a study published online Aug. 25 in the Journal of Clinical Oncology.
read article 



The Thunder God Vine, Assists by Nanotechnology, Could Shake Up Future Cancer Treatment

(Institute for Basic Science [Korea]) Aug 21, 2014 - Hepatocellular carcinoma (HCC) is the second leading cause of cancer-associated death worldwide.
read press release 



Light Therapy For Precancerous Skin Lesions

(WebMD/HealthDay News) Aug 27, 2014 - Treating pre-cancerous skin spots with a type of light therapy may be more effective than the usual therapy -- freezing the lesions with liquid nitrogen, a new study suggests.
read article 



Do More for Depressed Cancer Patients – Study

(The Guardian [UK]) Aug 27, 2014 - Three-quarters of cancer patients who also have clinical depression are not currently receiving any treatment for depression, a study has found.
read article 



Drug Shows Promise For Subset of Stage III Colon Cancer Patients

(AGA) Aug 28, 2014 - A subset of patients with stage III colon cancer had improved survival rates when treated with irinotecan-based therapy, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
read press release 



Study Questions Surveillance Colonoscopy

(MedPage Today/The Gupta Guide) Aug 27, 2014 - Removal of adenomatous polyps -- without follow-up surveillance colonoscopy -- led to a colorectal-cancer mortality similar to that of the general population, results of a large Norwegian cohort study showed.
read article (free registration required) 



Cancer Drugs Fund Subject to 'Value For Money' Assessment For First Time

(The Telegraph [UK]) Aug 28, 2014 - David Cameron's flagship cancer drugs fund receives an £80million boost but clinicians will assess whether treatments represent value for money for the first time.
read article 



FDA Lifts Partial Hold on OncoMed's Cancer Drug Trials

(Reuters) Aug 28, 2014 - OncoMed Pharmaceuticals Inc said the U.S. Food and Drug Administration lifted a partial hold on patient enrolments for three trials testing its experimental cancer drug, vantictumab.
read article 



UK Cancer Drug Fund Gets Extra 160 Million Pounds

(Reuters) Aug 28, 2014 - A fund that helps patients receive cancer medicines not routinely paid for by Britain's state health service is to get an extra 160 million pounds ($265 million), although the government is also taking a tougher line on prices.
read article 



Allergan Sets Dec. 18 Shareholder Vote in Valeant Takeover Fight

(Washington Post/Bloomberg) Aug 27, 2014 - Allergan Inc. shareholders will get the chance to vote on Dec. 18 whether to replace members of the drugmaker’s board as part of a $54 billion hostile takeover fight with Valeant Pharmaceuticals International Inc.
read article (free registration required) 



Pharma Tells the Federal Government: Transparency Works Both Ways

(Wall Street Journal/Pharmalot blog) Aug 26, 2014 - File this under ‘how ironic.’ Drug makers are asking for more transparency from the government agency that is requiring them to be more transparent about how much they pay doctors.
read article (paid subscription required) 



Amgen Heart Failure Drug Gets Priority Designation From FDA

(Wall Street Journal) Aug 27, 2014 - Amgen Inc. said U.S. regulators have granted a priority review designation for the company's new drug application for its prospective heart-failure treatment.
read article (paid subscription required)